All Blog Posts Tagged 'standard-of-care' (2)

FDA Approves Orphan Drug Erwinaze™ for Treatment of Acute Lymphoblastic Leukemia for patients with hypersensitivity to standard-of-care treatment

The U.S. Food and Drug Administration (FDA) has approved its orphan drug asparaginase Erwinia chrysanthemi (Erwinaze™ www.erwinaze.com , EUSA Pharma) for the treatment of acute lymphoblastic leukemia (ALL) in patients who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegaspargase chemotherapy drugs used to treat ALL. The new drug will…

Continue

Added by Peter Hofland, PhD on November 18, 2011 at 6:30pm — No Comments

Pre-Clinical Studies of Triphendiol Demonstrate Anti-proliferative Activity in Pancreatic Cancer

A rapid and aggressive spread into surrounding tissue, resistance to standard chemotherapy and a tendency to recur make pancreatic cancer one of the most challenging diseases to treat. The disease is also difficult to diagnose in its early stage, and patients usually present with incurable disease. It has a high mortality rate, and so far no therapy has been shown to significantly impact survival. Pancreatic cancer is considered an orphan cancer, because of its relatively… Continue

Added by Peter Hofland, PhD on June 27, 2011 at 6:30am — No Comments